Hyder Osman Mirghani
Hyder Osman Mirghani is an expert in Endocrinology at University of Tabuk (Saudi Arabia). As of October 2026, ScienceLeadR ranks Hyder Osman Mirghani in the top 1% of experts worldwide for Diabetes Mellitus, and in the top 1% of experts in Saudi Arabia for Glucose Metabolism Disorders. Hyder Osman Mirghani has authored 170 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 602 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Surgery - Public Health - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2015 - 2026
Number : 170
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Prevalence of Obstructive Sleep Apnea in the Adult Population of Saudi Arabia: A Systematic Review and Meta-analysis. PMID 42921354 — sleep apnea, obstructive, sleep, apnea, prevalence, sleep apnea syndromes | Int J Prev Med | 2026 | 0 |
| Preexisting diabetes and gestational diabetes as risk factors for autism spectrum disorder: an umbrella review. PMID 42780951 — diabetes mellitus, diabetes, gestational, bias, pregnancy, autism spectrum disorder, public health, autistic disorder, risk factors, diabetes mellitus, type 1, diabetes mellitus, type 2 | Front Public Health | 2026 | 0 |
| Clinical risk-aware reinforcement learning for latency-constrained healthcare IoT scheduling. PMID 42697903 — reinforcement, psychology, workload, learning | Sci Rep | 2026 | 1 |
| The crosstalk between polycystic ovary syndrome and Hashimoto thyroiditis: a systematic review and meta-analysis. PMID 42630159 — insulin resistance, insulin, thyroiditis, ovary, dyslipidemias, thyroid gland, polycystic ovary syndrome, hashimoto disease | Front Endocrinol (Lausanne) | 2026 | 0 |
| Glucagon-like receptor-1 agonists and impotence: A meta-analysis. PMID 42626264 — glucagon-like peptide receptors, erectile dysfunction, hormones, glucagon, therapeutics | World J Methodol | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map